"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"

Trial Profile

"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 26 Feb 2018

At a glance

  • Drugs Ciclosporin (Primary) ; Rituximab (Primary)
  • Indications Membranous glomerulonephritis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MENTOR
  • Most Recent Events

    • 21 Feb 2018 Planned End Date changed from 1 Oct 2017 to 1 Oct 2019.
    • 21 Mar 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
    • 20 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top